![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 1873-5576|10|2|200-209
ISSN: 1568-0096
Source: Current Cancer Drug Targets, Vol.10, Iss.2, 2010-03, pp. : 200-209
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Le Uyen Minh Shaker Dalia Sloat Brian Cui Zhengrong
Drug Development and Industrial Pharmacy, Vol. 34, Iss. 4, 2008-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Imaging of HER-2 Overexpression in Tumors for Guiding Therapy
Current Pharmaceutical Design, Vol. 14, Iss. 28, 2008-10 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Anti-HER2 Cancer Therapy and Cardiotoxicity
Current Pharmaceutical Design, Vol. 20, Iss. 30, 2014-09 ,pp. :